Pacira BioSciences (PCRX) Amortization of Goodwill (2024)

Pacira BioSciences' (PCRX) quarterly Amortization of Goodwill came in at $163.2 million in Q3 2024.

Pacira BioSciences (PCRX) Amortization of Goodwill (2024) Analysis & Trends

Pacira BioSciences' Amortization of Goodwill history runs 1 years deep, the most recent figure standing at $163.2 million for Q3 2024.

  • On a quarterly basis, Amortization of Goodwill changed N/A year-over-year to $163.2 million in Q3 2024; TTM through Dec 2025 was $163.2 million, a N/A change from a year earlier, with the FY2024 full-year figure at $163.2 million, changed N/A from the prior year.
  • Amortization of Goodwill was little changed at $163.2 million in Q3 2024 per PCRX's latest filing.
  • Across five years, Amortization of Goodwill topped out at $163.2 million in Q3 2024 and bottomed at $163.2 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.46 Bn 87.60 Bn -
2 Teva Pharmaceutical Industries 35.93 Bn 32.19 Bn 1.97 Bn
3 Zoetis 32.54 Bn 30.60 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.49 Bn 23.43 Bn 4.39 Bn
5 United Therapeutics 23.05 Bn 20.89 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.24 Bn 18.43 Bn 1.16 Bn
8 Neurocrine Biosciences 17.77 Bn 16.45 Bn 800.70 Mn
9 Elanco Animal Health 12.60 Bn 12.17 Bn 785.00 Mn
10 Pacira BioSciences 1.07 Bn 869.63 Mn 140.96 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 163.20 Mn
Sep 30, 2024 163.20 Mn